Regulatory Watch
FDA amends carcinogenicity testing requirements
Updated regulations eliminate requirement that a sponsor conduct oral, chronic, dose-type studies.
Read More
Copyright ©2024. All Rights Reserved BNP Media.
Design, CMS, Hosting & Web Development :: ePublishing